
News|Articles|April 11, 2025
A Turning Point in Retinal Neovascular Diseases
Author(s)Sponsored by Bayer
Advertisement
Newsletter
Keep your retina practice on the forefront—subscribe for expert analysis and emerging trends in retinal disease management.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Modern Retina
1
Johnson & Johnson’s TECNIS PureSee EDOF IOL cleared for US market
2
Eichenbaum Acorns: Collaborative retina care with Jeffry D. Gerson, OD, FAAO
3
NovaBridge, Visara report positive phase 2a results for dual VEGF-A/ANG-2 inhibitor VIS-101
4
Ocugen completes enrollment in liMeliGhT phase 3 trial of OCU400 for retinitis pigmentosa
5

































